Progress of hypertension pharmacological treatment
10.12092/j.issn.1009-2501.2022.04.015
- Author:
Guijian LIU
1
;
Kuan CHENG
1
;
Wenqing ZHU
1
;
Junbo GE
1
Author Information
1. Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases
- Publication Type:Journal Article
- Keywords:
Hypertension;
Pharmacological treatment;
Treatment progress
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2022;27(4):446-449
- CountryChina
- Language:Chinese
-
Abstract:
Hypertension is a common cardiovascular disease. Chinese guidelines for the management of hypertension, the global practice guidelines for hypertension of the International Hypertension Society (ISH) and the guidelines for the treatment of adult hypertension drugs of the World Health Organization have been issued successively, which play an important role in guiding the clinical medication of hypertension. Calcium channel blockers (CCB), angiotensin converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARBs), angiotensin receptor neprilysin inhibitor (ARNI), thiazide diuretics and β-receptor blockers are commonly used in clinical antihypertensive drugs. The goal of hypertension drug control, the application timing of hypertension drugs, the selection of combined medication scheme, the drug selection of hypertension complicated with other diseases, and the medication of gestational hypertension are all problems that clinicians need to master.
